Cambridge Healthtech Institute’s 13th Annual
Emerging Trends in Coverage and Reimbursement for Advanced Diagnostics
Assessing Policy Impacts and Building a Roadmap for the Future
August 18-19, 2025
Coverage and reimbursement for advanced and novel diagnostics are rapidly changing, and a deep understanding of the current and future landscape of coverage decisions can provide a distinct advantage. Cambridge Healthtech Institute’s 13th Annual conference on Emerging Trends in Coverage and Reimbursement for Advanced Diagnostics will bring payers, industry leaders, and policymakers together to discuss what coverage and reimbursement of novel diagnostics will look like going forward. Stakeholders across the industry will collaborate on topics including new legislation, MolDx, pharmacogenomics, commercialization challenges, and more. Presentations and panel discussions will provide a comprehensive outlook on the challenges and opportunities in diagnostic coverage and reimbursement today.
Coverage will include, but is not limited to:
- The impact of new legislation and policy reforms
- Price setting and valuation of novel diagnostics
- Finding pathways for coverage and reimbursement of novel diagnostics
- Exploring how coverage policies are applied at the state level
- Overcoming commercialization challenges and access barriers
- Reimbursement and coding for novel AI/ML-based technologies
The deadline for priority consideration is January 27, 2025.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: